Microneedle-mediated delivery of donepezil: Potential for improved treatment options in Alzheimer's disease
Microneedle-mediated delivery of donepezil: Potential for improved treatment options in Alzheimer's disease
复制标题
DOI:
10.1016/j.ejpb.2016.03.026
复制
发表时间:
2016-06-01
影响因子:
4.9
通讯作者:
Donnelly, Ryan F.
中科院分区:
文献类型:
--
作者:
Kearney, Mary-Carmel;Caffarel-Salvador, Ester;Donnelly, Ryan F.
Transdermal drug delivery is an attractive route of drug administration; however, there are relatively few marketed transdermal products. To increase delivery across the skin, strategies to enhance skin permeability are widely investigated, with microneedles demonstrating particular promise. Hydrogel-forming microneedles are inserted into the skin, and following dissolution of a drug loaded reservoir and movement of the drug through the created channels, the microneedle array is removed intact, and can then be readily and safely discarded. This study presents the formulation and evaluation of an integrated micro needle patch containing the Alzheimer's drug, donepezil hydrochloride. The integrated patch consisted of hydrogel-forming microneedles in combination with a donepezil hydrochloride containing film. Formulation and characterisation of plasticised films, prepared from poly(vinylpyrrolidone) or poly (methyl vinyl ether co-maleic anhydride/acid) (Gantrez (R)) polymers, is presented. Furthermore, in vitro permeation of donepezil hydrochloride across neonatal porcine skin from the patches was investigated, with 854.71 mu g +/- 122.71 mu g donepezil hydrochloride delivered after 24 h, using the optimum patch formulation. Following administration of the patch to an animal model, plasma concentrations of 51.8 +/- 17.6 ng/mL were obtained, demonstrating the success of this delivery platform for donepezil hydrochloride. (C) 2016 The Authors. Published by Elsevier B.V.